Search

everythinglearnresearchcommunity

for

Search:↓

Effective hair loss counseling requires understanding individual experiences, clear communication, and shared decision-making.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

Women with PCOS are much more likely to experience depression.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Stress-related hair loss was reversed with a special medication.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Hair loss affects self-esteem; patients seek effective, low side-effect treatments.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Alopecia areata affects quality of life more in adolescents than adults.

Homeopathic and biochemic treatments led to hair regrowth and improved confidence in a man with hair loss.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

Some alternative treatments may help with hair loss, but more evidence is needed to confirm their effectiveness.

Minoxidil helps hair growth and boosts self-esteem in balding men.